Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era

Open access

Abstract

PURPOSE: Survival after liver transplantation (LTX) has decreased in Germany since the implementation of Model for end-stage liver disease (MELD)-based liver allocation. Primary sclerosing cholangitis (PSC) is known for its otherwise excellent outcome after LTX. The influence of MELD-based liver allocation and subsequent allocation policy alterations on the outcome of LTX for PSC is analyzed. METHODS: This is a retrospective observational study including 126 consecutive patients treated with LTX for PSC between January 1, 1999 and August 31, 2012. The PSC cohort was further compared to all other indications for LTX in the study period (n=1420) with a mean follow-up of 7.9 years (SD 3.2). Multivariate risk-adjusted analyses were performed. Alterations of allocation policy have been taken into account systematically. RESULTS: Transplant recipients suffering from PSC are significantly younger (p<0.001), can be discharged earlier (p=0.018), and have lower 3-month mortality than patients with other indications (p=0.044). The observed time on the waiting list is significantly longer for patients with PSC (p<0.001), and there is a trend toward lower match MELD points in the PSC cohort (p=0.052). No improvement in means of short-term mortality could be shown in relation to alterations of allocation policy within the MELD era (p=0.375). Survival rates of the pre-MELD era did not differ significantly from those of the MELD era (p=0.097) in multivariate risk-adjusted analysis. Patients in the MELD era suffered pre-transplant significantly more frequently from dominant bile duct stenosis (p=0.071, p=0.059, p=0.048, respectively; chi2). CONCLUSIONS: Progress is stagnating in LTX for PSC. Current liver allocation for PSC patients should be reconsidered.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00423-014-1214-6

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Survival of patients with PSC versus patients with other indications leading to LTX
Fig. 1 Survival of patients with PSC versus patients with other indications leading to LTXCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 3

  1. German Medical Association (2008) Richtlinien zur Organtransplantation gem. § 16 TPG. Dtsch Arztebl 105:A1461–A1464
  2. German Medical Association (2012) Richtlinien zur Organtransplantation gem. § 16 Abs. 1 S. 1 Nrn. 2 u. 5 TPG. Dtsch Arztebl 108:A662–A674
  3. Eurotransplant Manual version 4.3; September 26, 2013; Chapter 5: 10–19

Cited by

See all 21

Metadata

Authors
Klose, J., Klose, M. A., Metz, C., Lehner, F., Manns, M. P., Klempnauer, J., Hoppe, N., Schrem, H., & Kaltenborn, A.
Affiliations
  • Heidelberg University (DE)
  • Medizinische Hochschule Hannover (DE)
  • Leibniz University Hannover (DE)
Corresponding author
Klose, Johannes
Venue
Langenbeck's Archives of Surgery
Published
2014-06-04
Volume
399
Issue
8
Pages
1021-1029
ISSN
  • 0023-8236 (ISSN-L)
  • 1435-2443
  • 1435-2451
OpenAlex
W2102192330
Cited by
21
References
33
Citations by year
2025: 1 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 3 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 2 · 2014: 3
FWCI
2.97
Type
journal article
Language
en
Open access
Locations
  • Langenbeck s Archives of Surgery (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) (submittedVersion, cc-by-nc-nd)
  • Institutional Repository of Leibniz Universität Hannover (Leibniz Universität Hannover) (submittedVersion, cc-by)
  • Leibniz Universität Hannover (cc-by)
Topics
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
liver transplantation, primary sclerosing cholangitis, MELD score, liver allocation policy, graft survival, waitlist time, bile duct stenosis, post-transplant mortality
MeSH terms
Adolescent, Adult, Aged, Child, Child, Preschool, Female, Germany, Health Policy, Humans, Length of Stay, Male, Middle Aged, Postoperative Complications, Retrospective Studies, Waiting Lists, Cholangitis, Sclerosing, Survival Rate, Liver Transplantation, Treatment Outcome, Risk Assessment, End Stage Liver Disease, Operative Time

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era. https://app.cochat.ai/papers/10.1007/s00423-014-1214-6
The paper
Klose, J., Klose, M. A., Metz, C., Lehner, F., Manns, M. P., Klempnauer, J., Hoppe, N., Schrem, H., & Kaltenborn, A. (2014). Outcome stagnation of liver transplantation for primary sclerosing cholangitis in the Model for End-Stage Liver Disease era. Langenbeck's Archives of Surgery. https://doi.org/10.1007/s00423-014-1214-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.